Crispr Screen
A CRISPR screen is a high throughput genetic perturbation method that uses CRISPR Cas9 to systematically knock out each gene in a genome and measure the effect on a biological phenotype of interest. This guide is written for experimental biologists, graduate students, and bioinformaticians who plan to design, execute, or analyze a CRISPR screen and need a source bounded practical framework. The NCBI Bookshelf provides authoritative technical reference material on CRISPR technology and serves as a starting point for understanding the molecular basis of Cas9 mediated genome editing.
The core principle involves delivering a library of single guide RNAs (sgRNAs) targeting thousands of genes into a cell population, applying a selective pressure, and using next generation sequencing to measure which sgRNAs become enriched or depleted. The EMBL EBI Training resources offer structured learning paths for the bioinformatics components of this workflow, from quality control to statistical hit calling. Understanding these fundamentals is essential before investing time and resources into a screen.
At a Glance
| Aspect | Description |
|---|---|
| Method | High throughput genetic perturbation using CRISPR Cas9 |
| Primary purpose | Identify genes required for or involved in a phenotype of interest |
| Screen types | Pooled (bulk population) or arrayed (well by well) |
| Biological readout | Enrichment or depletion of sgRNAs under selective conditions |
| Typical scale | Genome wide libraries target 18000 20000 genes with 4 10 guides per gene |
| Analysis output | Ranked gene lists with false discovery rate estimates |
| Validation requirement | Independent confirmation of top hits using orthogonal methods |
| Key data repository | NCBI Sequence Read Archive for depositing raw sequencing data |
What Is a Crispr Screen
A CRISPR screen combines genome editing with functional genomics to test the role of every gene in a specific biological process. Researchers design a pooled library of sgRNAs, deliver them into cells expressing Cas9, and then apply a selection such as drug treatment, infection, or fluorescence activated cell sorting. Cells with knockouts that confer a fitness advantage or disadvantage will be enriched or depleted in the final population. The Galaxy Training Network offers accessible workflows for processing the sequencing data that results from such screens, including quality control, alignment, and count matrix generation.
The power of this approach lies in its unbiased nature. Instead of testing one gene at a time, a CRISPR screen lets the phenotype reveal which genes matter. For example, a genome wide CRISPR screen identified the deubiquitinase OTUD5 as a cardioprotective factor in septic cardiomyopathy, as reported in Clinical and Translational Medicine cardiomyocyte enriched OTUD5 study. Similarly, researchers studying podocyte stress used a combination of snRNA seq and genome wide CRISPR screening to define the full transcriptional trajectory of podocyte injury, published in Cellular and Molecular Life Sciences podocyte stress CRISPR screen. These examples illustrate how the method can uncover both expected and unexpected gene functions.
Key Decision Points
Selecting the right screen design requires careful consideration of several interdependent factors. The first decision is between pooled and arrayed formats. Pooled screens are cost effective for genome wide surveys and work well when the phenotype can be selected by survival, proliferation, or a fluorescent marker. Arrayed screens, where each sgRNA is placed in a separate well, allow direct measurement of individual phenotypes but are limited to smaller gene sets due to cost and labor.
Three critical decision points deserve special attention.
Library design. The number of sgRNAs per gene directly affects statistical power. Four to six guides per gene is standard for genome wide libraries. Fewer guides increase false negative rates. More guides increase library cost and sequencing depth requirements. The Bioconductor repository contains packages such as CRISPRseek and GuideScan that help evaluate guide quality and off target potential before ordering a library.
Cell type and Cas9 delivery. Some cell lines tolerate lentiviral transduction well, others require ribonucleoprotein delivery or transient transfection. Cas9 must be stably expressed or delivered simultaneously. Primary cells and non dividing cells require alternative strategies such as CRISPR interference or activation rather than knockout.
Selection stringency and duration. Too little selection produces no signal. Too much selection kills all cells. Time course experiments can capture dynamic changes. The optimal selection condition depends on the phenotype and must be determined empirically in pilot experiments. The NCBI Sequence Read Archive hosts data from published screens that can guide expected effect sizes and required sequencing depths for various phenotypes.
Practical Workflow
A rigorous CRISPR screen follows a defined sequence of steps. Each step includes built in quality checks. The following workflow assumes a pooled screen with lentiviral delivery, which is the most common format for genome wide applications.
Step 1: Library amplification. The initial sgRNA library arrives as a plasmid pool. Amplify it in bacteria using transformation with sufficient colonies to maintain representation. The rule of thumb is to achieve at least 1000 fold coverage of the library. For a library of 100000 guides, plate at least 100 million colonies. Harvest plasmids and verify representation by sequencing.
Step 2: Virus production and titer. Package the library into lentiviral particles. Determine the viral titer precisely. The transduction efficiency must be kept low, typically below 30 percent, to ensure most cells receive at most one guide. This is known as a low multiplicity of infection and is essential for accurate assignment of phenotype to guide.
Step 3: Cell transduction and selection. Transduce cells at the optimized multiplicity of infection. Allow three to five days for Cas9 mediated knockout to occur. Then apply the selective condition. Include control samples collected at the start of selection to measure initial guide representation. The Galaxy Training Network provides detailed tutorials for designing these time points and control conditions in pooled screening experiments.
Step 4: Genomic DNA extraction and PCR. Harvest genomic DNA from control and selected cell populations. A minimum of 200 million cells is typically needed for genome wide screens to maintain coverage. PCR amplify the integrated sgRNA sequences using barcoded primers. Perform enough PCR reactions to avoid bottleneck effects. Pool the reactions and purify the amplicons.
Step 5: Next generation sequencing. Sequence the amplicons on an Illumina platform. Aim for at least 200 reads per guide in the control samples and proportionally deeper in selected samples. The NCBI Sequence Read Archive is the standard repository for depositing these sequencing data upon publication.
Step 6: Computational analysis. Align sequencing reads to the reference guide library using a dedicated pipeline. Generate count tables and normalize for sequencing depth. Use statistical methods such as MAGeCK or the Bioconductor package edgeR to identify significantly enriched or depleted guides. The Bioconductor ecosystem includes packages specifically designed for CRISPR screen analysis, including CRISPRcleanR for removing read count biases and MAGeCKFlute for visualization.
Step 7: Hit prioritization and validation. Rank genes by the strength and consistency of guide enrichment or depletion. Select top candidates for validation using individual sgRNAs in a secondary screen. Confirm the phenotype with an independent assay such as western blotting, qPCR, or a complementary perturbation method like RNA interference or small molecule inhibition.
The value of careful validation was demonstrated in a study on T cell lymphoma where a CRISPR screen identified PLK1 inhibition as a target for enhancing Brentuximab vedotin efficacy, as published in Leukemia PLK1 screen in T cell lymphoma. The screen hits required validation through multiple orthogonal approaches before the therapeutic hypothesis could be confirmed.
Common Mistakes
Off target effects remain the most frequent source of false positives in CRISPR screens. A single guide can cleave at genomic sites with up to three mismatches, producing unintended knockouts that confound the phenotype. This risk is amplified when using large libraries with variable guide quality. The EMBL EBI Training materials include modules on off target prediction and mitigation strategies.
Insufficient coverage is another critical error. If the starting cell number is too low, stochastic dropout of guides produces false positive depletion signals. The required cell number depends on the library size, not on the number of genes targeted. A library of 100000 guides requires at least 100 million cells at each harvest point to maintain 1000 fold coverage.
Using too few replicates or failing to account for batch effects reduces statistical power and increases false discovery rates. At least two biological replicates are necessary, and three are preferred. Each replicate should be an independent transduction, not a technical replicate of the same cell pool.
Selecting the wrong statistical model also undermines results. Early generation tools that assume normally distributed read counts perform poorly on CRISPR screen data, which often exhibits overdispersion. Modern methods based on negative binomial models, such as those available in Bioconductor packages, handle this data structure far more reliably.
Limits of Interpretation
CRISPR screens identify genes whose knockout affects a phenotype, but they do not reveal mechanism directly. A hit gene may be involved through direct regulation, indirect pathway compensation, or even off target effects. Follow up experiments are always necessary to understand the biological basis of the phenotype.
The method has systematic blind spots. Essential genes required for basic cell survival cannot be identified in dropout screens because their knockout kills the cell regardless of the phenotype under study. Similarly, genes with functional redundancy are rarely identified because another family member compensates for the loss. The NCBI Bookshelf discusses these limitations in the context of interpreting genetic interaction networks.
Phenotype specificity is another concern. A gene identified as important for drug resistance may also be important for general fitness. Distinguishing specific resistance mechanisms from general growth defects requires careful control experiments and statistical modeling that accounts for baseline fitness effects.
Batch effects between replicate screens can produce inconsistent results, especially when replicates are performed weeks or months apart. Changes in cell state, passage number, or reagent lots all contribute to variation. The Galaxy Training Network offers tutorials on detecting and correcting batch effects in high throughput screening data.
Finally, the model system matters. Findings in cancer cell lines may not translate to primary cells. Findings in one cell type may not generalize to another. A CRISPR screen is a hypothesis generating tool, not a definitive experiment. Every hit requires independent validation and careful interpretation within the context of the specific biological system being studied.
Frequently Asked Questions
What is the difference between a pooled and arrayed CRISPR screen? In a pooled screen, all sgRNAs are delivered together to a bulk cell population, and the phenotype is read out by sequencing. In an arrayed screen, each sgRNA is placed in a separate well, allowing direct measurement of individual phenotypes. Pooled screens are high throughput but limited to selection based readouts. Arrayed screens are lower throughput but can measure complex phenotypes like cell morphology or migration.
How many guides per gene are needed for reliable results? Most genome wide libraries include 4 to 10 guides per gene. Four guides provide minimal statistical power. Six to eight guides per gene is standard for most applications. Using fewer than four guides per gene dramatically increases false negative rates and makes it difficult to distinguish signal from noise.
What sequencing depth is required for a genome wide CRISPR screen? A minimum of 200 sequencing reads per guide in the reference sample is standard, and deeper coverage of 500 to 1000 reads per guide is preferred for the selected samples. For a library of 100000 guides, this translates to 20 million to 100 million reads per sample. Insufficient sequencing depth leads to increased noise and reduced statistical power.
How do I validate hits from a CRISPR screen? Validate top candidate genes using individual sgRNAs in a secondary screen. Use at least two independent sgRNAs per gene that differ in their targeting sequence to rule out off target effects. Confirm the phenotype with an orthogonal method such as RNA interference, small molecule inhibition, or overexpression rescue. Always validate the knockout at the protein level using western blotting or flow cytometry.
References and Further Reading
- NCBI Bookshelf: CRISPR Technology and Applications Authoritative reference on CRISPR Cas9 mechanism and screening methodology.
- EMBL EBI Training: CRISPR Screen Data Analysis Structured modules on bioinformatics analysis of pooled screens.
- Galaxy Training Network: CRISPR Screen Workflows Open source tutorials for processing and analyzing screen data.
- Bioconductor: CRISPR Screen Analysis Packages Software ecosystem for statistical analysis and visualization of screen results.
- NCBI Sequence Read Archive Public repository for depositing raw sequencing data from CRISPR screens.
- PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30 positive T cell lymphoma Published example of screen guided therapy discovery in leukemia.
- SnRNA seq and genome wide CRISPR screening define podocyte stress trajectory Combinatorial approach linking single cell transcriptomics with CRISPR screens.
- Genome wide CRISPR screen reveals TRIM25 in ribophagy Example of screen identifying a ubiquitin ligase in autophagy regulation.
- Cardiomyocyte enriched OTUD5 alleviates septic cardiomyopathy Screen based discovery of a deubiquitinase in cardiac inflammation.
- Low DYNLL1 resists epithelial jamming like state CRISPR screen application in oral epithelial biology.